This article follows an individual living with the long-term effects of a traumatic brain injury (TBI) across a six-week iboga microdosing journey, during which I provided education, ongoing support and psychological integration.

Six years after a severe traumatic brain injury changed the direction of her life, Carlie Ostrom travelled to Mexico for ibogaine treatment. What followed was an experience she describes not simply as relief from long-standing symptoms, but as a reconnection with herself.

Exploring the potential of psychedelics in brain injury recovery: a thematic analysis of participant narratives.

What would happen if the compulsive pull toward novelty, reward and constant input could be interrupted long enough for attention, motivation and impulse control to reorganise around a lower-stimulation baseline?

New 12-month follow-up data adds to a growing body of research exploring ibogaine's potential for traumatic brain injury.

Interest in psychedelic medicine for traumatic brain injury has accelerated rapidly in recent years, with ibogaine and psilocybin emerging as two of the most promising compounds under investigation.

A fascinating new case series has added to the growing conversation around Iboga and brain injury recovery.

Emerging evidence in individuals with traumatic brain injury suggests psychedelics may drive meaningful improvements in cognition, mood, and trauma, signalling a potential paradigm shift in neurorehabilitation.

I’ve conducted an independently led study exploring the effects of psychedelics on individuals living with brain injury.